Eric Woo

Eric WOO

Technical Analyst

Eric is responsible for project evaluation and investment document preparation.

Prior to Ginward, he began his career in 2014 in sales and marketing activities for medicinal products in pharmaceuticals. At both DKSH HK and Astellas Pharma HK, his main focus was on oncology products, including Amgen GCSF pipeline (filgrastim and pegfilgrastim) and Astellas’ blockbuster prostate cancer drug, enzalutamide, where he consistently outperformed the sales targets for these products.

After 2.5-year sales experience in the pharmaceutical sector, he began studies for a Master’s degree. During the programme, he held intern positions in the BASF Singapore agriculture marketing department and Merck KGaA Darmstadt OLED strategic marketing department, and completed his masters thesis on adhesive rheology at DELO Windach.

Eric is bilingual in English and Cantonese, and has some knowledge of Mandarin and German.

He obtained his Bachelor’s degree in Chemistry with First class honours from the University of Hong Kong in 2014, and his Master’s degree in Industrial Chemistry from the Technical University of Munich and National University of Singapore in 2018. He was awarded scholarships from TUM Asia-DAAD.

Edward Willems

Edward WILLEMS

Managing Director & Co-founder

Ginger Hsiao

Ginger HSIAO

Co-founder

Shang Hsiao

Shang HSIAO

Co-founder and Venture Partner

Benjamin Loh
Jaap Weiling

Jaap WIELING

Venture Partner and Scientific Advisor

Jessica Li

Jessica LI

Financial Analyst

Nithya

Nithya ALAGAPPAN

Technical Analyst

Gerard PNG

Financial Analyst

William ONG

Technical Analyst

Dr. Bert Tjeenk Willink

Advisor and Venture Partner

Andrew Lin

Andrew LIN

Advisor

Clark Su

Clark SU

Advisor

Adam Kirby

Adam KIRBY

Advisor

Jerry Hong

Jerry HONG

Advisor